glp 1 intracranial hypertension Idiopathic and the Challenge of Weight Loss Idiopathic Intracranial Hypertension | New

Saris DB, Vanlauwe J, Victor J et al

Another report showed that more than half of patients who stopped semaglutide or liraglutide (Saxenda, Novo Nordisk) maintained their weight a year later

In addition to the well-characterized catalytic activity, recent evidence has shown that certain GST isozymes can regulate mitogen-activated protein kinases or can facilitate the addition of glutathione to cysteine residues in target proteins ( S -glutathionylation)

Kornack DR, Rakic P

Minakova E, Lang J, Medel-Matus JS, Gould GG, Reynolds A, Shin D, Mazarati A, Sankar R

Drucker said although he discovered GLP-1, which is used in Ozempic, he does not receive any royalties as the patent has long expired